Professor Kausik Ray
Professor of Public Health, Imperial College London
Professor Kausik Ray is Professor of Public Health, Consultant Cardiologist, Deputy Director of Imperial Clinical Trials Unit and Head of Commercial Trials in the School of Public Health, Imperial College London, and President of the European Atherosclerosis Society (EAS).
Listed in Clarivate Analytics’ list of the top 1% Highly Cited Researchers in medicine globally in 2018, 2019 and 2020, he has an H index of 84, an i10 of 216 and around 90,000 citations. Key contributions have influenced European and American guidelines, his work on statins and diabetes risk has led to a global label change for statins by the FDA and EMEA.
He is involved in 8 trials in lipids and diabetes and is PI for ORION 1, 3, 11 and BETonMACE. He leads the EAS FH Studies Collaboration, the first global registry of FH with 70 countries and 62,000 cases, and is Senior PI for the TOGETHER study looking at cardiometabolic risk in vascular health checks in 250,000 people. His research focuses on preventing coronary disease, specifically lipids, diabetes, biomarkers, and risk prediction.